Dilutional Coagulopathy

Dilutional coagulopathy is a condition where abnormal blood clotting develops due to significant blood loss being replaced primarily with fluids or red blood cells that don't contain adequate clotting factors and platelets, effectively diluting the blood's remaining clotting ability. It's a recognised complication of major bleeding requiring large-volume transfusion.

It occurs when significant blood loss, such as from major trauma, surgery, or childbirth complications, is replaced with large volumes of fluids or red blood cells without proportionate replacement of clotting factors and platelets. This mismatch effectively dilutes the concentration of components needed for normal clotting.

Yes, it can worsen ongoing bleeding by impairing the body's ability to form effective blood clots, creating a potentially dangerous cycle if not promptly recognised and corrected. Prompt, balanced blood product replacement is important to break this cycle and control bleeding.

The main indication is ongoing or worsening bleeding despite efforts to control the original source, sometimes with oozing from multiple sites including surgical wounds or needle puncture sites. Blood tests showing abnormal clotting parameters confirm the diagnosis.

No, it's caused by the acute dilution effect of major blood loss and fluid replacement rather than being an inherited condition. It's not related to any specific inherited clotting disorder, though people with underlying clotting conditions may be at higher risk of complications from major bleeding generally.

Yes, treatment involves carefully balanced transfusion of blood products including clotting factor-containing plasma and platelets, alongside red blood cells, in a ratio designed to avoid or correct the dilution effect. This is a well-established part of modern major bleeding management protocols.

Management involves following established massive transfusion protocols that provide a balanced ratio of red blood cells, plasma and platelets, alongside regular blood testing to monitor clotting status and guide further treatment. Close collaboration between surgical, anaesthetic and haematology teams is essential during major bleeding events.

Diagnosis involves blood tests measuring clotting function and platelet counts in the context of major blood loss and transfusion, alongside clinical observation of any ongoing or unusual bleeding. Rapid, repeated testing during an actively bleeding emergency helps guide real-time treatment decisions.

Dilutional coagulopathy results specifically from the dilution effect of major blood loss and fluid replacement, while disseminated intravascular coagulation is a more complex condition involving widespread abnormal clotting activation throughout the body, often triggered by severe illness or infection, that consumes clotting factors and can occur alongside or independently of major bleeding. Distinguishing between these related but different conditions guides specific treatment approaches.

This is relevant in emergency and surgical settings involving major bleeding requiring significant transfusion, managed by specialist trauma, surgical, anaesthetic and haematology teams following established protocols. It's a hospital-based emergency management issue rather than something managed in outpatient or routine care.